When people hear the word “fat,” they often think about calories, cholesterol, or dietary choices. In clinical nutrition, however, some fats are essential because the human body cannot make enough of them on its own. That raises a practical question: how can a clinician tell whether someone is getting enough essential fatty acids?
One of the most interesting answers came from an older piece of nutritional biochemistry: the Holman Index, also called the triene-to-tetraene ratio.
The test is deceptively simple. It compares two fatty acids found in a blood-based fatty acid profile: Mead acid, a triene fatty acid, and arachidonic acid, a tetraene fatty acid. When essential fatty acid availability falls, the body changes how it handles these fatty acids. Mead acid can rise while arachidonic acid falls, pushing the ratio upward.
That biochemical shift is what makes the ratio useful.
Today, the Holman Index remains referenced in clinical nutrition, particularly when clinicians are evaluating essential fatty acid status in people whose dietary fat intake, absorption, or nutrition support may be unusual. At the same time, modern testing has made the interpretation more nuanced than simply looking at one number.
So what exactly does the Holman Index measure? Why did Ralph Holman develop the triene-to-tetraene ratio? What does a high ratio actually mean? And why is a ratio from decades ago still relevant to a modern blood test for essential fatty acid status?
This guide explains the history, chemistry, calculation, clinical meaning, limitations, and practical interpretation of the Holman index triene tetraene ratio EFAD diagnosis concept in plain English.
What Is the Holman Index?
The Holman Index is the ratio of Mead acid to arachidonic acid in plasma.
The basic equation is:
Holman Index = Mead acid ÷ arachidonic acid
Mead acid is also known as 20:3 n-9, meaning it contains 20 carbon atoms, three double bonds, and belongs to the omega-9 family.
Arachidonic acid is 20:4 n-6, meaning it contains 20 carbon atoms, four double bonds, and belongs to the omega-6 family.
Because Mead acid is the “triene” and arachidonic acid is the “tetraene,” the same measurement is commonly called the triene-to-tetraene ratio, abbreviated T ratio.
The important point is that this is not simply a measurement of how much fat someone eats.
It is a measurement of how the body's fatty acid metabolism is responding to limited essential fatty acid availability.
That difference explains why the test is so useful.
The simple definition
The Holman Index is a blood-based biochemical marker that measures the relationship between Mead acid and arachidonic acid. An elevated ratio can indicate that the body is compensating for inadequate essential fatty acid availability.
The calculation itself is straightforward. Interpreting it is more complicated.
Historically, a value around 0.20 or higher in plasma has commonly been used as a biochemical threshold for essential fatty acid deficiency, although thresholds and reference ranges vary by laboratory, population, specimen type, and clinical context. The original work by Ralph Holman used different experimental criteria, which is one reason the history of the cutoff is often oversimplified.
Why Did Ralph Holman Develop the Ratio?
To understand the Holman Index, it helps to step back from the modern laboratory report.
Ralph T. Holman was a major figure in the study of essential fatty acids and lipid metabolism. His research helped establish ways to evaluate whether an organism had enough essential fatty acids based not just on what was being eaten, but on what was happening to fatty acids inside tissues.
In 1960, Holman published research specifically examining the ratio of trienoic to tetraenoic fatty acids as a measure of essential fatty acid requirement.
The underlying idea was elegant.
If essential fatty acids are readily available, the body has access to the substrates needed to maintain normal production of downstream polyunsaturated fatty acids, including arachidonic acid.
When those essential fatty acids become scarce, the normal balance changes.
The body cannot simply manufacture linoleic acid or alpha-linolenic acid from scratch. Instead, it begins relying more heavily on other available fatty acids and shifts portions of its metabolic machinery toward omega-9 pathways.
One notable result is increased production of Mead acid.
That gave researchers something measurable.
Instead of asking only:
“Does this person have enough essential fatty acid in the diet?”
Holman’s approach allowed researchers to ask:
“What does the fatty acid pattern in the body reveal about essential fatty acid availability?”
That was a much more powerful question for nutritional research and clinical assessment.
The Biochemistry Behind the Holman Index
The triene-to-tetraene ratio makes more sense once the underlying fatty acid pathways are clear.
Humans require certain polyunsaturated fatty acids from the diet because they cannot synthesize the essential parent fatty acids in sufficient amounts.
Two major dietary essential fatty acids are:
- Linoleic acid, an omega-6 fatty acid
- Alpha-linolenic acid, an omega-3 fatty acid
These fatty acids participate in metabolic pathways that lead to other longer-chain fatty acids.
Arachidonic acid is one important downstream omega-6 fatty acid.
Mead acid belongs to the omega-9 family and follows a different route. Under ordinary conditions, its formation is relatively limited.
When essential fatty acid availability becomes inadequate, however, the metabolic picture changes.
What happens when essential fatty acids are low?
The body has enzymes that act on different unsaturated fatty acids. When sufficient omega-6 and omega-3 fatty acid substrates are available, those pathways have access to their preferred substrates.
When essential fatty acid availability drops, more of the available oleic acid can be directed toward the omega-9 pathway.
That can increase production of Mead acid.
At the same time, lower availability of linoleic acid can reduce the supply of fatty acids needed to maintain normal arachidonic acid levels.
The result is a recognizable biochemical pattern:
Mead acid goes up.
Arachidonic acid tends to go down or become relatively lower.
The triene-to-tetraene ratio rises.
That is the basic metabolic logic behind the Holman Index.
What Does “Triene-to-Tetraene” Actually Mean?
The terminology can sound intimidating, but the names are mainly describing molecular structure.
A triene has three double bonds.
A tetraene has four double bonds.
For the Holman Index:
- Mead acid = triene
- Arachidonic acid = tetraene
So the ratio is:
Mead acid / arachidonic acid
This is why you may see several terms used almost interchangeably:
Holman Index
Triene-to-tetraene ratio
T ratio
Mead acid-to-arachidonic acid ratio
Mead acid/arachidonic acid ratio
They refer to the same basic measurement when the ratio is being calculated from the appropriate plasma fatty acid measurements.
Why Mead Acid Is So Important
If you have never encountered Mead acid before, it may seem strange that such a relatively obscure fatty acid could become a useful nutritional marker.
Its importance comes from what its presence can reveal about metabolism.
Mead acid is produced from oleic acid, an omega-9 fatty acid. Under conditions of adequate essential fatty acid availability, relatively little Mead acid is produced.
When essential fatty acids become scarce, however, the body's fatty acid metabolism can redirect more substrate toward this pathway.
That makes an increase in Mead acid more than an isolated laboratory curiosity.
It can serve as a metabolic clue.
This is one reason the Mead acid level is frequently discussed alongside the triene-to-tetraene ratio when evaluating essential fatty acid status.
Why Arachidonic Acid Is the Other Half of the Ratio
A ratio needs context.
Mead acid provides the “triene” side, but arachidonic acid provides the “tetraene” side.
Arachidonic acid is a major long-chain omega-6 fatty acid. Its availability is linked to the metabolism of linoleic acid.
When essential fatty acid intake is inadequate, the supply of linoleic acid can fall. That can alter downstream omega-6 fatty acid production, including arachidonic acid.
Now the ratio becomes informative in two directions.
The numerator may increase.
The denominator may decrease.
That combination produces a larger ratio than would normally be expected.
In other words, the Holman Index is not valuable simply because Mead acid exists in the bloodstream.
It is valuable because the relationship between Mead acid and arachidonic acid changes when essential fatty acid metabolism is disrupted.
How Is the Holman Index Calculated?
The formula is simple:
Mead acid ÷ arachidonic acid = Holman Index
Suppose, purely as an illustration, that a plasma fatty acid profile reported:
- Mead acid: 0.60
- Arachidonic acid: 6.00
The calculation would be:
0.60 ÷ 6.00 = 0.10
That would produce a triene-to-tetraene ratio of 0.10.
Now imagine a second example:
- Mead acid: 1.20
- Arachidonic acid: 4.00
The calculation would be:
1.20 ÷ 4.00 = 0.30
The second ratio is substantially higher.
These numbers are only illustrations of the arithmetic. A real laboratory report has to be interpreted using the laboratory's reference range, specimen type, fatty acid measurement method, age, nutrition history, and clinical context.
That last point matters.
A ratio should not be pulled from a report and interpreted in isolation.
What Does a High Triene-to-Tetraene Ratio Mean?
A high triene-to-tetraene ratio generally means that Mead acid is elevated relative to arachidonic acid, creating a biochemical pattern associated with inadequate essential fatty acid availability.
A commonly cited plasma threshold is 0.20 or greater, but that number is not universal in every testing situation. Modern reviews have pointed out that reference ranges can vary and that newer fatty acid testing methods may produce lower ratios in healthy populations.
This is why the phrase “high Holman Index” should be treated as a starting point rather than an automatic diagnosis.
A clinician may also look at:
- Linoleic acid
- Alpha-linolenic acid
- Mead acid
- Arachidonic acid
- Other omega-3 fatty acids
- Other omega-6 fatty acids
- The overall fatty acid profile
- Nutrition history
- Absorption considerations
- Nutrition-support formulation
- The laboratory's own reference interval
The broader pattern often tells a more useful story than one number.
Why the 0.20 Threshold Gets So Much Attention
Search for the Holman Index and you will quickly encounter 0.20.
That number is widely cited because later clinical work established a plasma triene-to-tetraene ratio of approximately 0.20 or higher as a biochemical indicator of essential fatty acid deficiency.
But there is an important historical detail.
Holman's original experimental work used a different benchmark, with a ratio of about 0.4 appearing in his early work as an indicator of deficiency under the experimental conditions being studied. Later human data and clinical use helped establish the lower 0.20 threshold that is now commonly referenced.
This distinction explains why older papers and newer clinical articles can appear to disagree.
They are not necessarily talking about the same population, specimen, laboratory methodology, or clinical endpoint.
A useful way to think about the numbers
Rather than memorizing a single cutoff, think of the ratio as a biochemical signal.
A lower ratio generally indicates that Mead acid is relatively low compared with arachidonic acid.
A rising ratio indicates a stronger shift toward omega-9 Mead acid production relative to arachidonic acid.
A value at or above a commonly used clinical threshold can raise concern for biochemical essential fatty acid deficiency, but it should be interpreted in context.
That is a much more accurate way to understand what the number means.
Is the Holman Index a Blood Test?
Yes, but there is an important technical qualification.
The Holman Index is not usually a standalone test ordered separately from all other fatty acid measurements.
Instead, it is a ratio calculated from a fatty acid profile, traditionally using plasma measurements of Mead acid and arachidonic acid.
So when people search for a “blood test for essential fatty acid deficiency,” they may actually be looking for a broader fatty acid profile from which the triene-to-tetraene ratio can be calculated.
That distinction matters because the commonly cited plasma threshold should not simply be transferred to every biological sample.
For example, fatty acid composition can differ between plasma and red blood cell membranes, meaning a ratio measured in one specimen type is not necessarily interpreted using the same cutoff as the other.
Why Plasma Matters
The Holman Index has historical and clinical meaning because of the way it was established and used.
A ratio is not just a mathematical formula. It is a formula tied to a specific measurement context.
If a laboratory measures Mead acid and arachidonic acid in plasma, the resulting ratio can be compared with plasma reference information.
If the same fatty acids are measured in another biological fraction, the baseline pattern may be different.
That is why “my ratio is 0.18” does not mean much without knowing:
- What specimen was tested?
- Which laboratory performed the analysis?
- How were the fatty acids measured?
- What reference range was supplied?
- Is the patient receiving nutrition support?
- What does the rest of the fatty acid profile show?
The number is meaningful only when those questions are answered.
What the Holman Index Does — and Does Not — Tell You
One of the easiest mistakes is to treat the Holman Index like a universal nutrition score.
It is not.
The index is designed to detect a metabolic pattern associated with essential fatty acid deficiency.
It does not tell you everything about dietary quality.
It does not measure total dietary fat.
It does not tell you whether a person's overall diet is healthy.
It does not independently determine whether someone has consumed enough calories.
It also does not identify every possible reason for an altered fatty acid profile.
The index is best understood as one piece of biochemical evidence.
That distinction is especially important because modern nutrition support formulas can contain very different lipid compositions, and those differences can affect circulating fatty acid patterns.
Why Modern Nutrition Has Made Interpretation More Complicated
The Holman Index was developed in an era when fatty acid testing and clinical nutrition were much less technologically sophisticated than they are today.
Modern nutrition support can use multiple lipid emulsions containing different mixtures of fatty acids.
That creates a problem for simple ratio interpretation.
For example, an individual receiving a lipid formulation relatively rich in oleic acid may show an increase in Mead acid for reasons that require more careful interpretation than the traditional textbook model suggests.
In other words, the metabolic pathway still matters, but the source of the fatty acids entering the body matters, too.
Modern reviews therefore emphasize that the triene-to-tetraene ratio should not automatically be treated as the only evidence of essential fatty acid status. Individual fatty acid concentrations and the composition of the nutrition formulation may need to be considered alongside the ratio.
Why Clinicians Still Reference the Holman Index
It is fair to ask why a ratio developed decades ago remains relevant when laboratories can now measure dozens of fatty acids with highly sensitive analytical techniques.
The answer is simplicity.
The Holman Index distills a complicated metabolic relationship into a single number.
It also has physiological meaning.
When essential fatty acid availability drops, the body responds in a recognizable way. Mead acid becomes more prominent, while arachidonic acid becomes relatively less prominent. The ratio captures that shift.
That makes it useful as a shorthand marker.
The ratio also has historical continuity. Researchers, dietitians, pharmacists, and clinicians studying clinical nutrition can compare modern measurements with decades of literature using the same basic biochemical concept.
That does not make the index infallible.
It makes it useful.
The Difference Between a Marker and a Cause
This distinction is critical when interpreting any laboratory test.
The Holman Index is a marker.
It does not cause a change in fatty acid status.
An elevated ratio reflects a particular metabolic environment.
Think of it like a dashboard warning light. The light is useful because it tells you something has changed, but it does not necessarily tell you the complete reason for that change.
A clinician may therefore investigate the person's nutritional intake, absorption, recent nutrition support, fatty acid profile, and overall medical context.
The ratio helps guide that investigation.
It does not replace it.
Can You Have a High Ratio Without Obvious Symptoms?
Yes.
This is one reason the biochemical marker can be valuable.
Changes in fatty acid composition can appear before obvious clinical manifestations become prominent. Research and modern reviews describe biochemical evidence of essential fatty acid deficiency as potentially preceding outward signs.
That gives the test an important role in monitoring people who may be at higher nutritional risk.
However, a laboratory finding does not automatically mean a person will experience obvious symptoms, nor does the absence of symptoms prove that essential fatty acid status is normal.
The laboratory result and the person’s full nutritional picture have to be considered together.
What Symptoms Might Raise the Question of Fat Deficiency?
Because your search may begin with a symptom rather than a lab test, it is useful to understand why essential fatty acid status sometimes gets investigated.
Historically described signs of significant deficiency can involve changes in the skin, hair, growth, and other physiological functions.
But symptom-based identification is imperfect.
Many symptoms are nonspecific and can have numerous nutritional or non-nutritional explanations.
That is why biochemical assessment can be more informative than trying to diagnose essential fatty acid deficiency based on one symptom alone.
The modern question is less:
“Do I have this one symptom?”
and more:
“Does my nutrition history and laboratory profile show a pattern consistent with inadequate essential fatty acid availability?”
That is the territory where the Holman Index becomes useful.
Does a Vegan Diet Cause Essential Fatty Acid Deficiency?
Not inherently.
A plant-based diet can provide both major dietary essential fatty acids.
Linoleic acid is found in foods such as sunflower seeds, safflower products, sesame seeds, walnuts, and many other plant foods. Alpha-linolenic acid is particularly associated with foods such as flaxseed, chia seeds, hemp seeds, and walnuts.
The more relevant question is whether a person's overall intake provides enough essential fatty acids and whether those nutrients are being absorbed and metabolized appropriately.
A vegan or plant-forward diet is therefore not automatically synonymous with inadequate essential fatty acid intake.
For readers interested in the broader lifestyle side of plant-based living, The Dharma Store offers ethically oriented apparel, including Vegan T-Shirts, alongside a broader message centered on compassion and mindful living.
What Does the Holman Index Have to Do With Omega-3 and Omega-6 Fats?
The Holman Index is traditionally calculated using a Mead acid-to-arachidonic acid ratio, which focuses heavily on the omega-9 and omega-6 pathways.
That can make the test seem narrower than the phrase “essential fatty acid status” suggests.
The body's fatty acid pathways, however, are interconnected.
Omega-3 and omega-6 fatty acids use overlapping enzymes and metabolic machinery. Changes in availability of one family can affect the handling of another.
This means that an elevated triene-to-tetraene ratio is best understood as a sign of broader changes in essential fatty acid metabolism rather than a direct measurement of one single dietary nutrient.
Still, the test has an important limitation: the ratio itself does not directly measure every relevant omega-3 fatty acid.
That is one reason comprehensive fatty acid panels can provide more context than the Holman Index alone.
Why the Triene-Tetraene Ratio Is Sometimes Called an EFAD Index
The phrase EFAD index is another common search term for the same concept.
EFAD stands for essential fatty acid deficiency.
Because the triene-to-tetraene ratio was developed as a biochemical indicator of essential fatty acid status, it became known as an index of deficiency.
But “index” is an important word.
It means the ratio functions as an indicator or measure, not that the ratio itself is the entire diagnostic process.
In clinical practice, the index is considered alongside other information.
That is particularly important today because laboratory technology can identify individual fatty acids with much greater precision than was available when Holman first developed the concept.
Common Misunderstandings About the Holman Index
“A high ratio means I eat too little fat.”
Not necessarily.
The Holman Index is concerned with essential fatty acid metabolism, not total dietary fat intake.
Someone could consume plenty of fat while still having an unusual essential fatty acid profile.
Conversely, someone consuming a relatively moderate-fat diet could have an adequate supply of essential fatty acids.
The type of fat matters.
“The Holman Index measures omega-3 directly.”
No.
The classic Holman Index is the ratio of Mead acid to arachidonic acid.
It therefore provides an indirect picture of essential fatty acid status rather than a direct measurement of every omega-3 fatty acid.
“A value above 0.20 always proves deficiency.”
Not by itself.
A ratio around or above 0.20 is a commonly cited biochemical threshold in plasma, but modern literature notes variation between populations, laboratories, analytical methods, and nutritional contexts.
“The test is obsolete because it is old.”
Also no.
The age of the test is not the same thing as the usefulness of the underlying biology.
The metabolic adaptation that produces more Mead acid when essential fatty acid availability is inadequate remains biologically relevant.
What has changed is the sophistication of interpretation.
How a Clinician Might Approach an Elevated Ratio
Imagine a laboratory report shows an elevated triene-to-tetraene ratio.
A thoughtful interpretation would not stop at the ratio.
The clinician might review:
- The actual Mead acid concentration.
- The arachidonic acid concentration.
- Linoleic acid and alpha-linolenic acid levels.
- The broader fatty acid pattern.
- The laboratory's stated reference interval.
- The type of specimen tested.
- Current nutrition intake.
- Any nutrition-support formulation being used.
- Whether absorption or utilization may be altered.
- Whether the result changes over time.
This is one reason the Holman Index is best understood as a diagnostic clue rather than a standalone answer.
Why Trends Can Be More Informative Than One Result
A single laboratory value is a snapshot.
A sequence of values can tell a story.
Suppose a person receiving specialized nutrition support has a progressively increasing triene-to-tetraene ratio. If that trend occurs alongside falling linoleic acid and rising Mead acid, the overall pattern may be more meaningful than any isolated number.
Now imagine the ratio falls after the person's essential fatty acid intake is adjusted.
That trajectory provides additional evidence that nutritional fatty acid availability was affecting the laboratory pattern.
Again, the numbers have to be interpreted by a qualified clinician, but the principle is straightforward:
A changing ratio can reveal a changing metabolic state.
What Makes the Holman Index Such an Elegant Test?
There is something unusually clever about the measurement.
It does not merely ask how much of one fatty acid is present.
It examines a relationship between competing metabolic outcomes.
That makes the ratio responsive to a physiological shift.
If the body is producing more Mead acid while arachidonic acid becomes relatively less abundant, the ratio captures both changes at once.
Mathematically, that is powerful.
Biologically, it is even more interesting.
The number is essentially a compressed summary of what the fatty acid pathways are doing.
That is why such a simple equation has survived for so many years.
The Historical Legacy of Ralph Holman
Ralph Holman's contribution was larger than one laboratory ratio.
His work helped establish a framework for understanding essential fatty acids as biologically necessary nutrients whose absence could be recognized through changes in tissue lipids.
The triene-to-tetraene ratio was valuable because it transformed an abstract nutritional concept into something measurable.
Instead of saying:
“Essential fatty acids appear to matter.”
Researchers could ask:
“How does the body's fatty acid composition change when essential fatty acid availability changes?”
That shift—from observation to quantification—is the heart of Holman's diagnostic development.
His 1960 paper on the trienoic-to-tetraenoic relationship became part of the historical foundation for using fatty acid patterns as biochemical indicators of nutritional status.
Why the Holman Index Still Matters in Clinical Nutrition
Modern testing can measure much more than Holman could measure when the index was first proposed.
Yet the index remains useful because it connects laboratory data with physiology.
A clinician looking at a fatty acid profile is not simply counting molecules.
They are looking for patterns.
An elevated Mead acid level.
A reduced essential fatty acid supply.
A relatively reduced arachidonic acid concentration.
A higher triene-to-tetraene ratio.
Together, these findings can point toward a common nutritional explanation.
That pattern recognition is the enduring strength of the Holman Index.
A Practical Way to Read a Holman Index Result
If a lab report includes a triene-to-tetraene ratio, start with four questions.
First: What specimen was tested?
Plasma is especially important when discussing the traditional Holman Index and its commonly cited thresholds.
Second: What does the laboratory list as its reference range?
Modern laboratories may have different ranges based on their analytical method and reference population.
Third: What do the individual fatty acids show?
Look beyond the ratio to Mead acid, arachidonic acid, linoleic acid, alpha-linolenic acid, and other relevant fatty acids.
Fourth: What was happening nutritionally when the sample was taken?
Diet, nutrition support, and the fatty acid composition of supplemental products can influence the result.
Those four questions prevent many of the most common interpretation errors.
Is the Holman Index Still Used Today?
Yes, although its role is more nuanced than the phrase “diagnostic ratio doctors still use” might suggest.
Contemporary clinical nutrition literature continues to discuss the Holman Index as a marker of essential fatty acid status, especially in settings where inadequate essential fatty acid delivery is a concern.
At the same time, recent literature has questioned whether the traditional cutoff and ratio should always be treated as sufficient on their own. Modern fatty acid profiles, population-specific reference ranges, and changing nutrition-support formulations have made comprehensive interpretation more important.
So the most accurate answer is:
The Holman Index is still relevant, but it is best used as part of a broader fatty acid assessment rather than as an isolated number.
That is a stronger and more useful understanding than either extreme—calling the test obsolete or treating it as infallible.
What Should You Remember About the Holman Index?
The entire concept can be reduced to one metabolic story.
When essential fatty acids are adequately available, the body's fatty acid pathways operate with their usual substrate supply.
When essential fatty acid availability becomes inadequate, the balance shifts.
More oleic acid can be routed toward Mead acid production.
Arachidonic acid availability can decline.
The triene-to-tetraene ratio rises.
Holman recognized that this relationship could be used as a measurable indicator of essential fatty acid status.
Decades later, the same basic concept still appears in clinical nutrition because the biology behind the ratio remains meaningful.
The laboratory technology has changed.
The nutritional formulas have changed.
The reference ranges have evolved.
The fundamental metabolic signal has not disappeared.
Frequently Asked Questions
What is the Holman Index?
The Holman Index is the ratio of Mead acid to arachidonic acid in plasma. It is also called the triene-to-tetraene ratio or T ratio and is used as a biochemical indicator of essential fatty acid status.
What is the triene-to-tetraene ratio used for?
The triene-to-tetraene ratio is used to identify a biochemical pattern associated with essential fatty acid deficiency. A higher ratio generally reflects increased Mead acid relative to arachidonic acid.
What is the normal Holman Index?
There is no single universal “normal” number that applies to every testing situation. A plasma ratio of approximately 0.20 or higher is commonly cited as a biochemical threshold for essential fatty acid deficiency, but laboratories may use different reference ranges and modern testing can produce lower values in healthy populations.
Why does Mead acid increase during essential fatty acid deficiency?
When essential fatty acid availability is low, the body can redirect more oleic acid into the omega-9 pathway, increasing production of Mead acid. That metabolic adaptation is one of the main reasons Mead acid is useful as a marker.
Is the Holman Index a blood test for essential fatty acid deficiency?
It is a blood-based measurement, but it is more accurate to think of it as a ratio calculated from a plasma fatty acid profile rather than a completely separate standalone blood test.
Can the Holman Index diagnose essential fatty acid deficiency by itself?
Not reliably in every situation. The ratio is best interpreted with the individual fatty acid concentrations, laboratory reference ranges, specimen type, nutrition history, and other clinical information.
Final Takeaway
The Holman Index is a remarkably simple answer to a complicated nutritional question.
It asks whether the relationship between two fatty acids—Mead acid and arachidonic acid—has shifted in a way that suggests inadequate essential fatty acid availability.
That idea dates back to Ralph Holman's pioneering work on fatty acid metabolism. His insight was that nutritional status could be detected through the body's biochemical response, not just through an inventory of what someone had eaten.
Today, the Holman index triene tetraene ratio EFAD diagnosis concept remains relevant because it captures that response in a single number.
But the smartest way to use the ratio is not to memorize one cutoff and stop there.
Look at the specimen.
Look at the individual fatty acids.
Look at the laboratory's reference range.
Look at the nutrition context.
Then interpret the ratio as part of the larger metabolic picture.
That is the real legacy of the Holman Index: not merely a number, but a practical way of seeing what essential fatty acid metabolism is doing inside the body.
The information in this article is for educational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional regarding dietary or health concerns.